Todd Foley, Director at RHYTHM PHARMACEUTICALS, INC. (RYTM), sold 193,842 shares at $20.47 ($3.9M) on 2020-05-26, disclosed to the SEC on 2020-05-26.
Open-market sale of $3.9M RYTM by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $20.25 | 25,594 | $518K | 13.2% |
| 2 | $20.25 | 25,594 | $518K | 13.2% |
| 3 | $20.13 | 26,906 | $542K | 13.8% |
| 4 | $20.13 | 26,906 | $542K | 13.8% |
| 5 | $20.47 | 44,421 | $909K | 23.1% |
| 6 | $20.47 | 44,421 |
| $909K |
| 23.1% |
| Total | $20.32 avg | 193,842 | $3.9M | 100% |
| Filing → |
| ITOS | SELL | 2021-10-12 | $2.8M | — | Filing → |
| ITOS | SELL | 2021-09-20 | $5.2M | — | Filing → |
| RPTX | SELL | 2021-07-13 | $1.8M | — | Filing → |